Vischer assisted Swiss Nuclides in this transaction . Swiss Nuclides AG, a developer of novel radionuclide PET tracers for the precision diagnostics, has raised CHF 2.6m...
Swiss Nuclides’ CHF 2.6 Million Series A Financing Round
UMB Solutions AG’s Acquisition of Ubitec AG
Vischer advised the sellers on all legal aspects of the transaction. ubitec AG, a developer of innovative software solutions for digitization, was acquired by UMB Solutions...
DomoSafety’s Serie B Financing Round
VISCHER advised DomoSafety SA on the transaction. DomoSafety SA, a leading company in the digital health segment developing innovative solutions in the field of patient safety,...
Haya Therapeutics’ CHF 18 Million Seed Round
VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round. HAYA Therapeutics SA, a company developing precision medicines that target tissue and...
Haya Therapeutics’ CHF 18 Million Seed Round
VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round. HAYA Therapeutics SA, a company developing precision medicines that target tissue and...
Oculis SA’s $57 Million Series C Financing Round
Vischer advised Oculis SA on the deal, while Walder Wyss advised Hyfinity Investments. Oculis S.A., a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
Unsere Champions’ Entry Into Swiss Market
Vischer and McDermott Will & Emery advised Unsere Champions on the deal. Unsere Champions, a successful operator of day nurseries and kindergartens in southern Germany, acquired,...
Loomis’ Acquisition of SecurePost AG
VISCHER advised Loomis. Loomis, a Sweden-based and listed provider of cash handling services for banks, retailers and other commercial clients, has, through its wholly owned subsidiary...
Relief Therapeutics Holding AG’s CHF 10 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright LLC, as sole placement agent for the offering, while VISCHER advised Relief regarding the Swiss legal aspects of this transaction. RELIEF THERAPEUTICS...
CITIC Capital Partners’ $50 Million Investment in MedAlliance SA
VISCHER advised CITIC on all Swiss law matters. Trustar Capital (formerly known as CITIC Capital Partners), a private equity affiliate of CITIC Capital Holdings Limited, has...